- QMRO Home
- William Harvey Research Institute
- Centre for Biochemical Pharmacology
- Plasma lipid mediator (LM) profiling identifies hyper- and hypo-activated groups of patients with ACLF and targeted 20% human albumin solution infusion recalibrates abnormalities
Browse
Administrators only